Cargando…

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome

Shiga toxin-producing E. coli (STEC) produces Stx1 and/or Stx2, and Subtilase cytotoxin (SubAB). Since these toxins may be present simultaneously during STEC infections, the purpose of this work was to study the co-action of Stx2 and SubAB. Stx2 + SubAB was assayed in vitro on monocultures and cocul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Álvarez, Romina S., Gómez, Fernando D., Zotta, Elsa, Paton, Adrienne W., Paton, James C., Ibarra, Cristina, Sacerdoti, Flavia, Amaral, María M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402323/ https://www.ncbi.nlm.nih.gov/pubmed/34437406 http://dx.doi.org/10.3390/toxins13080536

Ejemplares similares

Action of Shiga Toxin Type-2 and Subtilase Cytotoxin on Human Microvascular Endothelial Cells
por: Amaral, María M., et al.
Publicado: (2013)

Ouabain Protects Human Renal Cells against the Cytotoxic Effects of Shiga Toxin Type 2 and Subtilase Cytotoxin
por: Amaral, María M., et al.
Publicado: (2017)

Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions
por: Álvarez, Romina S., et al.
Publicado: (2016)

Crosstalk between Human Microvascular Endothelial Cells and Tubular Epithelial Cells Modulates Pro-Inflammatory Responses Induced by Shiga Toxin Type 2 and Subtilase Cytotoxin
por: Álvarez, Romina S., et al.
Publicado: (2019)

Escherichia coli Subtilase Cytotoxin
por: Paton, Adrienne W., et al.
Publicado: (2010)

Effects of Escherichia Coli Subtilase Cytotoxin and Shiga Toxin 2 on Primary Cultures of Human Renal Tubular Epithelial Cells
por: Márquez, Laura B., et al.
Publicado: (2014)

Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes
por: Hu, Chih-Chi Andrew, et al.
Publicado: (2009)

Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome
por: Hostetter, Shannon J, et al.
Publicado: (2014)

Effects of Shiga Toxin Type 2 on Maternal and Fetal Status in Rats in the Early Stage of Pregnancy
por: Sacerdoti, Flavia, et al.
Publicado: (2014)

Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Abrey Recalde, Maria J., et al.
Publicado: (2017)

A New Family of Potent AB(5) Cytotoxins Produced by Shiga Toxigenic Escherichia coli
por: Paton, Adrienne W., et al.
Publicado: (2004)

Subtilase cytotoxin from Shiga-toxigenic Escherichia coli impairs the inflammasome and exacerbates enteropathogenic bacterial infection
por: Tsutsuki, Hiroyasu, et al.
Publicado: (2022)

Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
por: Mayer, Chad L., et al.
Publicado: (2012)

Novel Aspects of the SubA Subunit of the Subtilase Cytotoxin
por: Sessler, Katharina, et al.
Publicado: (2022)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2020)

Molecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variant
por: Funk, Joschua, et al.
Publicado: (2013)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
por: Chang, Hye Jin, et al.
Publicado: (2014)

Subtilase cytotoxin induces a novel form of Lipocalin 2, which promotes Shiga-toxigenic Escherichia coli survival
por: Yahiro, Kinnosuke, et al.
Publicado: (2020)

Correction: Molecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variant
por: Funk, Joschua, et al.
Publicado: (2014)

Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?
por: Bielaszewska, Martina, et al.
Publicado: (2007)

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Buelli, Simona, et al.
Publicado: (2019)

New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome
por: Petruzziello-Pellegrini, Tania N, et al.
Publicado: (2013)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities
por: McCoy, Nicole, et al.
Publicado: (2014)

Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina
por: Torti, Jeronimo F, et al.
Publicado: (2021)

Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome
por: Liu, Yang, et al.
Publicado: (2022)

Draft Genome Sequences of Five Shiga Toxin-Producing Escherichia coli Isolates Harboring the New and Recently Described Subtilase Cytotoxin Allelic Variant subAB(2-3)
por: Tasara, Taurai, et al.
Publicado: (2017)

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy
por: Firczuk, M, et al.
Publicado: (2013)

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000
por: Tozzi, Alberto E., et al.
Publicado: (2003)

Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome
por: Detzner, Johanna, et al.
Publicado: (2020)

Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania
por: Falup-Pecurariu, Oana, et al.
Publicado: (2019)

Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome
por: Wijnsma, Kioa L., et al.
Publicado: (2020)

Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden
por: Hua, Ying, et al.
Publicado: (2021)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management
por: Travert, Benoit, et al.
Publicado: (2021)

Heparin-induced thrombocytopenia following Shiga-toxin-associated hemolytic uremic syndrome: a case report
por: Rigamonti, Elia, et al.
Publicado: (2022)

Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic–uremic syndrome: a pilot study
por: Neu, Charles, et al.
Publicado: (2023)

Variants of Escherichia coli Subtilase Cytotoxin Subunits Show Differences in Complex Formation In Vitro
por: Krause, Maike, et al.
Publicado: (2019)

Shiga Toxin-Producing Escherichia coli Infections during Pregnancy
por: Sacerdoti, Flavia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9df91rfaicv3sudj0nt4rgadiq